NIH-funded research R01 grant

Myocardial fibrosis and fat in ART-treated women with HIV in sub-Saharan Africa

Official title: Myocardial Fibrosis and Steatosis Burden and Region-Specific Predictors of Progression among ART-treated Women with HIV infection in sub-Saharan Africa (The MUTIMA Study)

Funded at University of Washington · NIH-11594185 · Data updated 2026-11-12

This project studies heart tissue changes in women with HIV in sub-Saharan Africa who are on antiretroviral therapy, to understand why they’re at higher risk for heart problems as they age.

More Fibrosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startAugust 7, 2023
Project endMay 31, 2027
Funding year2026
Award (this year)$347,491
NIH project number3R01HL167645-04S2
Project IDNIH-11594185 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are ART-treated women with HIV in sub-Saharan Africa who are willing to undergo cardiac imaging and follow-up assessments.

Less likely to help

Individuals without HIV or those not receiving ART may not benefit from these findings.

What this research studies

If funded, researchers will use advanced heart imaging to measure fibrosis and fat in the heart of ART-treated women with HIV in SSA. The study aims to identify region-specific factors that predict progression of this heart damage over time. By focusing on women, the work seeks clues about why heart failure and sudden death are more common in this group and how to prevent it. The findings could guide targeted prevention and treatment strategies for heart disease in this population.

Why it matters

Potential benefit: Better understanding of heart disease risk in HIV-positive women could lead to earlier detection and tailored prevention strategies.

How similar studies have gone: Previous studies show that heart tissue changes can predict outcomes, but this project is among the first to characterize it specifically in ART-treated women with HIV in SSA.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Longenecker, Chris Todd — University of Washington
  • Study coordinator: Longenecker, Chris Todd

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.